Christopher John Kenney

Chief Medical Officer, Xenon Pharmaceuticals Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.7M

Companies

Latest trade

Aug 28, 2026

Companies

Xenon Pharmaceuticals Inc.Chief Medical Officer −$0.7M

Trades

XENE Sold 7,068 shares at $60.25 · planned $0.4M Aug 28

XENE Sold 1,410 shares at $55.23 · planned $0.1M Mar 13

XENE Sold 2,771 shares at $60.11 · planned $0.2M Mar 10

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.